146 related articles for article (PubMed ID: 32224327)
1. Does minimum follow-up time post-diagnosis matter? An assessment of changing loss of life expectancy for people with cancer in Western Australia from 1982 to 2016.
Wright CM; Moorin RE
Cancer Epidemiol; 2020 Jun; 66():101705. PubMed ID: 32224327
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.
Baade PD; Youlden DR; Andersson TM; Youl PH; Walpole ET; Kimlin MG; Aitken JF; Biggar RJ
Cancer Causes Control; 2016 Aug; 27(8):955-64. PubMed ID: 27306518
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM; Baade PD
Cancer Epidemiol; 2020 Apr; 65():101686. PubMed ID: 32062407
[TBL] [Abstract][Full Text] [Related]
4. Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.
Baade PD; Youlden DR; Andersson TM; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
BMJ Open; 2015 Apr; 5(4):e006740. PubMed ID: 25869684
[TBL] [Abstract][Full Text] [Related]
5. Impact of area-level socioeconomic status and accessibility to treatment on life expectancy after a cancer diagnosis in Queensland, Australia.
Kou K; Dasgupta P; Aitken JF; Baade PD
Cancer Epidemiol; 2020 Dec; 69():101803. PubMed ID: 32927295
[TBL] [Abstract][Full Text] [Related]
6. Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989-2019.
Maas CCHM; van Klaveren D; Visser O; Merkx MAW; Lingsma HF; Lemmens VEPP; Dinmohamed AG
EClinicalMedicine; 2023 Jun; 60():101994. PubMed ID: 37214634
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data.
Wright CM; Halkett G; Carey Smith R; Moorin R
BMC Cancer; 2020 Jul; 20(1):625. PubMed ID: 32631311
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
11. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. The loss in expectation of life after colon cancer: a population-based study.
Andersson TM; Dickman PW; Eloranta S; Sjövall A; Lambe M; Lambert PC
BMC Cancer; 2015 May; 15():412. PubMed ID: 25982368
[TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
[TBL] [Abstract][Full Text] [Related]
15. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
17. Estimating life expectancy and related probabilities in screen-detected breast cancer patients with restricted follow-up information.
Straatman H; Verbeek AL; Peer PG; Borm G
Stat Med; 2004 Feb; 23(3):431-48. PubMed ID: 14748037
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the Number of Cancer Deaths Avoided Due to Improvements in Cancer Survival since the 1980s in the Australian Population, 1985-2014.
Dasgupta P; Cramb SM; Kou K; Yu XQ; Baade PD
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1825-1831. PubMed ID: 32699079
[TBL] [Abstract][Full Text] [Related]
19. Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.
Syriopoulou E; Bower H; Andersson TM; Lambert PC; Rutherford MJ
Br J Cancer; 2017 Oct; 117(9):1419-1426. PubMed ID: 28898233
[TBL] [Abstract][Full Text] [Related]
20. Slower increase in life expectancy in Australia than in other high income countries: the contributions of age and cause of death.
Lopez AD; Adair T
Med J Aust; 2019 May; 210(9):403-409. PubMed ID: 31025719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
